A Deal with the Devil

We’re being told there’s no option but to use drugs like Ozempic to control our weight

One in eight American adults have now used weight-loss drugs like Ozempic, I reported on Saturday. That’s no surprise, because 40% of American adults are now obese.

There’s something of a Klondike feeling in the air when it comes to obesity these days, at least if you’re a company like Novo Nordisk or Eli Lilly that has a GLP-1-receptor-agonist product to sell. That’s the technical name for the class of drugs to which Ozempic and Mounjaro and most of the other new “miracle” weight-loss drugs belong. They signal satiety and alter the transit of food through the digestive system by activating GLP-1 receptors in the body.

These companies are already making enormous bank from their new products, but they know the money they’re making now is only a fraction of the money they could be making from America—and the world’s—ever-expanding waistlines.

This is especially true, since these companies know—even if users don’t—that their products will have to be used long term, maybe for years or even decades if users want to keep the weight off. Maybe a lifetime.

An executive from Eli Lilly said as much in a conference call last year.

“Unfortunately, tirzepatide is probably like every other drug we have which requires you to take it to continue to get the benefits.”

Unfortunately. Hardly.

I’m all for a slimmer world. Being overweight or, even worse, obese is a disaster, individually and, at the levels we’re currently experiencing, collectively too. Obesity is a drain on the public finances of the US to the tune of nearly $200 billion a year, and that’s definitely a conservative estimate.

Think how many border walls that could build and how many deportation flights $200 billion could pay for. You could have a dozen walls separating the US from Mexico and relocate every member of MS-13 in the US to Antarctica or, better yet, to some location directly above a patch of shark-infested sea, in the dead of night.

Happy trails, Alejandro!

We absolutely need to do something about obesity. Not only is it draining the public finances: it’s making us weaker, more docile, easier to control.

Cast your mind back to the pandemic. Remember: One demographic that consistently defied the lockdowns, social restrictions and vaxx mandates was gymbros. Think of our Canadian friend Chris Sky, and the extent to which he was persecuted, but bravely persisted to call “bullsh*t” on the whole thing.

And that wasn’t a coincidence, that gymbros were such visible opponents of medical tyranny. If we weren’t so sick as a society, if we weren’t so inured to dependency on the government and Big Pharma, I don’t think we’d have ever put up with all that nonsense. Forty years ago, thirty years ago, probably even twenty years ago, we just wouldn’t have had it. Today, though, the gymbros are a last bastion of independent physical existence, of the virtues of self-reliance and courage.

The history of testosterone and politics remains to be written—and maybe I’ll be the one to write it.

But the question I ask, again and again, is: Are these drugs the answer?

No, I don’t think so.

Let’s put aside, for now, the issue of side effects. I’ve written elsewhere, at length, about how unfortunate users of Ozempic are inhaling the contents of their own stomachs on operating tables, being left facing diarrhea “forever” and even dying from chronic bowel obstructions because the transit of food through their guts completely shuts down.

There are fertility concerns too. We’ve heard about the phenomenon of “Ozempic babies,” where overweight women who lose weight with Ozempic or a similar drug suddenly find themselves pregnant because their reproductive apparatus has been shunted back into life, but we hear less about the fact that Ozempic use during pregnancy has been shown to inhibit fetal growth significantly in mice. That’s not good.

Let’s put to one side, too, the fact that the only long-term studies we have of GLP-1 receptor agonist use, from rodents, suggest the drugs reliably cause thyroid tumours. Again, not good.

Like I said, let’s just think about the primary issue, which is the use of these new drugs to combat obesity.

The gravamen, as far as I’m concerned, is this: that by relying on these drugs to reduce obesity on a society-wide scale, we are simply ceding control of yet another aspect of our lives to Big Pharma.

Once upon a time, people managed their own weight. But now, we need an outside agency to do so for us. This obviously makes us less free. Big Pharma’s power increases as our diminishes.

And of course Big Pharma, as well as Big Food, is encouraging this, because by making us believe that there’s nothing we can do to control our own weight, short of some miraculous pharmaceutical discovery, they make more money. It’s a simple proposition. If you ran a company like Novo Nordisk or Eli Lilly, chances are you’d do the same.

This is a clear example of a process dubbed “iatrogenesis” by the philosopher Ivan Illich. “Iatrogenesis” means “medical harm,” and Illich extended the traditional application of this term from things like botched surgeries and misprescribed drugs to the process by which people have their agency stripped from them by the growing medicalisation of society. If you pay attention to one recommendation I make, read Illich’s 1974 book Medical Nemesis, also known as The Limits of Medicine.

Iatrogenesis happened to mothers with the replacement of breastmilk with formula, for example, and it’s definitely happening now with these new obesity drugs.

What iatrogenesis does, in the case of obesity, is prevent us from addressing the root causes of obesity. Complicated though these may be, they boil down to the fact that we are no longer living in a manner that is compatible with our evolved nature as human beings.

We eat food—processed food—that barely qualifies as nutrition. We don’t move. We park ourselves and our children in front of bright screens from morning till night, disrupting the light-based circadian rhythms that govern our body’s metabolic and hormonal processes. We are chronically stressed. We’re exposed, everywhere we go, to a witch’s brew of toxic chemicals that interfere with our bodies in ways we’re still desperately trying to understand.

None of this, not one bit of it, will be addressed if we try to solve obesity with drugs. Obesity drugs will just sustain the whole inhuman system.

At the same time, though, I can’t say I’m not torn. I’m a realist. I think it’s unlikely in the extreme that we’re going to see a broad health-based movement emerge any time soon to challenge the real causes of our sickness.

There are faint murmurs of such a thing in the presidential campaign of Robert F. Kennedy Jr., but he’s a crypto-libtard and he won’t get elected.

And so instead, we’re left with these drugs and their makers.

But it’s a deal with devil. And the devil has been having his way a lot around these parts lately.


Saturday Emergency Broadcast! Globalist Depopulation Operation Exposed By Covid Whistleblower